Search results
Found 10585 matches for
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
New funding for development of world's first lung cancer vaccine
Clinical Trials Research Translational Research
22 March 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Gulnar Abdullayeva receives an Azerbaijan Presidential Award for Youth 2024
Awards & Appointments Research
23 February 2024
Prof. Ester Hammond and Dr Monica Olcina travel to Warsaw for the first meeting of the EU Horizon funded consortium – HIT-GLIO
Funding Research Tumour Microenvironment
29 January 2024
Researchers develop easy-to-deploy federated learning system that safeguards patient data
Artificial Intelligence Research
24 January 2024
The technique, which builds on recent advances in decentralised machine learning, uses inexpensive pre-programmed micro-computers, making it easy to deploy in hospitals and cheap to scale up.
Festive Science Image Competition Winners
Department FLASH Radiation Research
5 December 2023
Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.
Robert Watson Awarded ACP McElwain and Presidents Prize
Awards & Appointments Research
23 October 2023
Dr Robert Watson has won one of three McElwain and President's Prizes from the Association of Cancer Physicians for his DPhil work undertaken with Professor Ben Fairfax.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa.
Research Translational Research
23 October 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
Clinical Trials DNA Damage & Repair Immunology Research Translational Research
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.
Machine Learning Predicts SETD2 Mutation Status with Unprecedented Accuracy using DNA methylation
Publication Research
11 August 2023
In a pan-cancer analysis spanning 24 different cancer type, researchers shed light on the critical role of SETD2 in tumourigenesis.
Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies
Clinical Trials Research
27 July 2023
Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.
Multi-cancer blood test shows real promise in NHS trial
Clinical Trials Innovation Research Translational Research
2 June 2023
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.
The Howat Foundation to fund Chair in Clinical Oncology
Awards & Appointments Department Innovation Research
10 May 2023
Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation
New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years
Innovation Publication Research
6 April 2023
A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, aimed at identifying the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.
Mark Hill becomes Fellow of the Institute of Physics and Engineering in Medicine
Awards & Appointments
16 March 2023
Dr Mark Hill was awarded the honour of Fellow of the Institute of Physics and Engineering in Medicine (FIPEM) after ‘demonstrating scientific and professional attainment of outstanding merit’.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
Department Immunology Research
16 December 2022
New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Tiffany Ma wins the inaugural BACR Student Impact Award 2022
Awards & Appointments Outreach Public Engagement
28 October 2022
Oxford gets £122m funding for healthcare research
Funding Research Translational Research
14 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the city’s two National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRC).
The Department represented at the European Radiation Research Society annual conference
Events FLASH Radiation Research
30 September 2022
Researchers from the Department of Oncology attend the prestigious European Radiation Research Society (ERRS) in annual conference in Catania, Italy to present their research in Radiation Oncology.
Funding to research metformin’s ability to delay or prevent cancers driven by the mutated TP53 gene
Clinical Trials Research
29 September 2022
A research project embedded within the Metformin in Li Fraumeni (MILI) trial will investigate metformin’s mechanism of action when taken as a preventative for mTP53-driven cancers.
Unique Clinical Imaging Dataset Released for Artificial Intelligence Research to Accelerate Diagnosis of Prostate Cancer
Clinical Trials General
23 September 2022